Nucala - supply shortage
Resolved
mepolizumab
Shortage
Human
Shortage information
The shortage affecting Nucala has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Nucala
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- mepolizumab
- Therapeutic area (MESH)
- Asthma
- Pharmaceutical forms affected
- Pre-filled pen
- Strengths affected
- 40 mg
- 100 mg
- Availability of alternatives
- Yes
Key dates
- First published
- Last updated